Results 1 to 10 of about 3,835 (176)
OMG! A proteomic determinant of neurodegenerative resiliency [PDF]
Background Biofluid proteomics can enhance our understanding of the neurodegenerative mechanisms underlying Alzheimer’s disease and related dementias (ADRDs). Oligodendrocyte myelin glycoprotein (OMG) is a brain-specific protein implicated in myelination,
Michael R. Duggan +55 more
doaj +4 more sources
Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort. [PDF]
PurposeTo compare ocular myasthenia gravis (OMG) and generalized myasthenia gravis (GMG) in a South Korean cohort through an integrated analysis of clinical characteristics, diagnostic findings, and treatment patterns.MethodsWe conducted a retrospective ...
Chaerin Kwon, Jeeyoung Oh, Hyun Jin Shin
doaj +2 more sources
Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis [PDF]
PurposeThis study aimed to evaluate the value of the OMGRate and MG-QOL 15 in assessing quality of life (QoL) before and after treatment in ocular myasthenia gravis (OMG) and to validate the applicability of OMGRate in the Chinese OMG population ...
Ting Tang +7 more
doaj +2 more sources
OMG: Open Molecule Generator [PDF]
Computer Assisted Structure Elucidation has been used for decades to discover the chemical structure of unknown compounds. In this work we introduce the first open source structure generator, Open Molecule Generator (OMG), which for a given elemental ...
Peironcely Julio E +6 more
doaj +4 more sources
Robotic thymectomy for ocular myasthenia gravis: a case series from a UK tertiary centre [PDF]
Background Ocular myasthenia gravis (oMG), characterised by ptosis and diplopia, may progress to generalised MG (gMG). Thymectomy is established for seropositive gMG, but its role in oMG remains unclear.
David Lawrence +5 more
doaj +2 more sources
Ocular myasthenia gravis management [PDF]
Ocular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite
Mark J. Kupersmith +2 more
doaj +2 more sources
Proanthocyanidin-Rich Cranberry Extract Lowers Glycemia in Established Obesity by Delaying Glucose Absorption. [PDF]
Schematic summary of the metabolic effects and proposed mechanisms of action of proanthocyanidin‐rich cranberry extract (PRCE) supplementation in mice with established diet‐induced obesity housed under thermoneutral (30°C) or cold‐exposed (10°C) conditions.
Beji S +16 more
europepmc +2 more sources
Desarrollo de nuevos diseños vegetales: Mejora genética vs transformación genética y edición génica
El objetivo de esta reflexión es realizar un estudio comparativo sobre la eficacia, eficiencia técnica y costo de las tecnologías más importantes para el desarrollo de nuevos diseños vegetales, incluyendo la mejora genética, la transformación genética y ...
Pedro Martínez Gómez
doaj +1 more source
Cognitive processes require striatal activity. The underlying molecular mechanisms are widely unknown. For this reason the striatal transcriptome of young (YM), aged cognitively impaired (OMB), and unimpaired (OMG) male rats was analyzed.
Volker Korz +10 more
doaj +1 more source

